Dover has entered into a definitive settlement to acquire Malema Engineering Corp, a US designer and producer of high-precision, mission-critical flow-measurement and management devices for the biopharmaceutical, semiconductor and industrial sectors.
Image: dizain/Adobe Stock.
Malema’s products will expand Dover’s biopharma single-use manufacturing providing, which already contains Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in Minutes , Florida, and with services in San Jose, California, Singapore, South Korea and India, Malema expects to generate approximately US$40 million–45 million in income in the course of the full yr 2022.
When Guaranteed closes, Malema will turn out to be a half of the PSG business unit within Dover’s Pumps & Process Solutions phase.
“We see an amazing long-term growth alternative within the bioprocessing industry pushed by a strong and growing pipeline of effective novel biologic drugs, biosimilars, protein therapies, non-COVID mRNA vaccines, as properly as budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the rising adoption of more efficient single-use production processes helps a strong outlook for our choices of single-use parts to end-customers. We imagine that pairing Malema’s know-how with our current portfolio of single-use pumps for biopharma processing will significantly enhance the accuracy and value proposition of our options to our prospects.”
“We are methodically constructing out our biopharma platform through proactive capability additions, new product growth, and opportunistic acquisitions of highly-attractive niche element technologies,” stated Richard Tobin, president and CEO of Dover. “Malema represents a strategic and highly-complementary flow-control and sensing expertise and further strengthens our sensor portfolio with new proprietary expertise. In addition to engaging biopharma applications, we count on sturdy growth within the semiconductor space on the capability enlargement and re-shoring tailwinds.”
Share